Satellos Bioscience MSLE
NASDAQ MSLE
$8.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Return on Assets [ROA] (2026)

Updated

Satellos Bioscience (MSLE) recorded Return on Assets [ROA] of -73.57% in the quarter ended Jun 30, 2026, down 10.06 percentage points from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Return on Assets [ROA] (2026) Analysis & Trends

For the year ended Dec 31, 2025, Satellos Bioscience reported Return on Assets [ROA] of -60.16%, down 6.18 percentage points from the prior year.

  • Across earlier years, Return on Assets [ROA] came in at -53.97% in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Satellos Bioscience 131.40 Mn 131.40 Mn - -73.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -73.57%
Mar 31, 2026 -63.51%
API Access

Satellos Bioscience Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MSLE&period=max&api_key=YOUR_API_KEY